Voorbeelden van het gebruik van Described in section in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Financial
-
Colloquial
-
Official
-
Ecclesiastic
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
This is further described in Section 3.5.
The management guidelines for these adverse reactions are described in section 4.4.
The company as described in section 1;
The management guidelines for these adverse reactions are described in section 4.4.
Mensen vertalen ook
Betway must successfully verify Your identity as described in Section 3.
Where GoDaddy uses any authorised Sub-processor as described in Section 6.1.
The holder described in section III-D will help you do this.
These organisations are described in Section 1.2.
Limits in relation to the use of unsecured debt instruments The Eurosystem applies limits to the use of unsecured debt instruments as described in Section 6.4.2.
These institutions are described in Section 2 below.
privacy settings as further described in Section 5.A.
This is further described in Section 3.6,“Disk Organization”.
Signs and symptoms of ITP are described in section 4.
The use of NME methodologies is described in Section 15 of the Chinese WTO Accession Protocol,
Except for the warranties described in section 7.
you can do so by adding a copy of the license to the manual, as described in section 6 of the license.
Prepare the solution as described in section 6.6.
These effects are described in section 4,‘Possible side effects.
The procedure for reconstitution is described in section 6.6.
3(Language Competences) as described in Section II, each proposal must involve partners from at least three participating countries,
Prepare uranyl-containing media as described in section 3.
List back to jessie as described in Section A.2,"Checking your sources list.
Signs and symptoms of kidney disease are described in section 4.
This behaviour is clearly described in section 14.9 of the HTTP specifications.
The nature of our legitimate interests is described in Section E.1.
Label albumin with 125I as described in Section 3.1 and previously reported7.
The broad design of this regulatory framework is described in section 3.3.
Progress in 2008 is described in section 2 of this report.